TCR-T immunotherapy targeting EBV-associated malignancies

被引：0
|
作者：
Jia, L. [1 ]
Chen, H. [1 ]
Liu, F. [1 ]
Wu, D. [2 ]
Ding, Z. [1 ]
Rui, W. [1 ]
Zhao, X. [1 ]
Chen, W. [2 ]
Lin, X. [1 ]
机构：
[1] Tsinghua Univ, Beijing, Peoples R China
[2] Zhejiang Univ, Hangzhou, Zhejiang, Peoples R China
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2019年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P2286
引用
收藏
页码：1722 / 1722
页数：1
相关论文
共 50 条
  • [21] An efficient method to identify virus-specific TCRs for TCR-T cell immunotherapy against virus-associated malignancies
    Chen, Lei
    Dong, Lianhua
    Ma, Yipeng
    Wang, Juntao
    Qiao, Dongjuan
    Tian, Geng
    Wang, Mingjun
    BMC IMMUNOLOGY, 2021, 22 (01)
  • [22] Eliciting protective T cell immunity against EBV-associated malignancies by vaccination
    Ruhl, J.
    Citterio, C.
    Leung, C.
    Munz, C.
    EUROPEAN JOURNAL OF CANCER, 2018, 92 : S19 - S19
  • [23] Off-the-shelf EBV-specific T-cell Immunotherapy for EBV-associated PTLD
    O'Reilly, Maeve
    Peggs, Karl S.
    TRANSPLANTATION, 2020, 104 (10) : 1972 - 1973
  • [24] Moving towards an immunotherapeutic cure for EBV-associated malignancies
    Moss, DJ
    TISSUE ANTIGENS, 2005, 66 (05): : 498 - 498
  • [25] Vasculogenic mimicry formation in EBV-associated epithelial malignancies
    Tong Xiang
    Yu-Xin Lin
    Wenlong Ma
    Hao-Jiong Zhang
    Ke-Ming Chen
    Gui-Ping He
    Xiao Zhang
    Miao Xu
    Qi-Sheng Feng
    Ming-Yuan Chen
    Mu-Sheng Zeng
    Yi-Xin Zeng
    Lin Feng
    Nature Communications, 9
  • [26] Vasculogenic mimicry formation in EBV-associated epithelial malignancies
    Xiang, Tong
    Lin, Yu-Xin
    Ma, Wenlong
    Zhang, Hao-Jiong
    Chen, Ke-Ming
    He, Gui-Ping
    Zhang, Xiao
    Xu, Miao
    Feng, Qi-Sheng
    Chen, Ming-Yuan
    Zeng, Mu-Sheng
    Zeng, Yi-Xin
    Feng, Lin
    NATURE COMMUNICATIONS, 2018, 9
  • [27] NEXT GENERATION LMP2A-TARGETING ENGINEERED TCR-RECOMBINANT T CELLS WITH INDUCIBLE IL-18 EXPRESSION AS PROMISING APPROACH FOR EBV-ASSOCIATED MALIGNANCIES
    Mausberg, Philip
    Dragon, Anna C.
    Stoll, Sven
    Spieler, Peter
    Cobo, Maria Fernanda Lammoglia
    Tischer-Zimmermann, Sabine
    Blasczyk, Rainer
    Nerreter, Thomas
    Hudecek, Michael
    Schambach, Axel
    Hansmann, Leo
    Maecker-Kolhoff, Britta
    Bonifacius, Agnes
    Eiz-Vesper, Britta
    HLA, 2023, 102 : 17 - 18
  • [28] Targeting the TCR β-constant region for specific immunotherapy of T-cell malignancies
    Maciocia, P. M.
    Wawrzyniecka, P.
    Philip, B.
    Akarca, A.
    Marafioti, T.
    Pule, M. A.
    HUMAN GENE THERAPY, 2016, 27 (11) : A31 - A32
  • [29] Therapies based on targeting Epstein-Barr virus lytic replication for EBV-associated malignancies
    Li, Hongde
    Hu, Jianmin
    Luo, Xiangjian
    Bode, Ann M.
    Dong, Zigang
    Cao, Ya
    CANCER SCIENCE, 2018, 109 (07): : 2101 - 2108
  • [30] Induction of EBV latent membrane protein-2A (LMP2A)-specific T cells and construction of individualized TCR-engineered T cells for EBV-associated malignancies
    Zhang, Chaoting
    Tan, Qin
    Li, Shance
    Shen, Luyan
    Zhang, Jingtao
    Liu, Ying
    Yang, Wenjun
    Lu, Zheming
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (07)
12345